{"transactions":[{"id":700841,"issuer":{"id":6149,"kind":"organization","name":"COMPUGEN LTD"},"owners":[{"id":27831,"kind":"person","name":"Silberman David","position":1,"cik":"0001867998","reported_name":"Silberman David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Share Option (right to buy)","published_at":"2026-07-30T20:11:29.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests 25% on September 30, 2027 and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":26000,"derivative":{"exercise_price":2.26,"expiration_date":"2036-07-29","underlying":"Ordinary Shares","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001178913-26-003727","document":"zk2635775.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1119774/000117891326003727/zk2635775.xml","form_type":"4"}},{"id":700840,"issuer":{"id":6149,"kind":"organization","name":"COMPUGEN LTD"},"owners":[{"id":27831,"kind":"person","name":"Silberman David","position":1,"cik":"0001867998","reported_name":"Silberman David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-30T20:11:29.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs vest 25% on September 30, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":55000,"source":{"system":"sec-edgar","filing":"0001178913-26-003727","document":"zk2635775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1119774/000117891326003727/zk2635775.xml","form_type":"4"}},{"id":1684520,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":27831,"kind":"person","name":"Silberman David","position":1,"cik":"0001867998","reported_name":"Silberman David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-08T21:39:04.000Z","date":"2024-01-04","kind":"grant","planned":false,"acquired":true,"shares":136500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in equal quarterly installments of 11,375 over a three year period starting January 8,\n2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":366500,"source":{"system":"sec-edgar","filing":"0001209191-24-001146","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919124001146/doc4.xml","form_type":"4"}},{"id":1873524,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":27831,"kind":"person","name":"Silberman David","position":1,"cik":"0001867998","reported_name":"Silberman David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-05-31T21:10:09.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":24500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") granted in April 2023 and vested upon achievement of certain performance conditions. The RSUs converted into Issuer's common stock on a one-for-one basis."}],"balance_after":230000,"source":{"system":"sec-edgar","filing":"0001209191-23-033141","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919123033141/doc4.xml","form_type":"4"}},{"id":1916596,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":27831,"kind":"person","name":"Silberman David","position":1,"cik":"0001867998","reported_name":"Silberman David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-20T10:00:15.000Z","date":"2023-04-17","kind":"grant","planned":false,"acquired":true,"shares":97500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in equal quarterly installments of 8,125 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":205500,"source":{"system":"sec-edgar","filing":"0001209191-23-024936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919123024936/doc4.xml","form_type":"4"}},{"id":2199209,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":27831,"kind":"person","name":"Silberman David","position":1,"cik":"0001867998","reported_name":"Silberman David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-02T00:00:36.000Z","date":"2022-07-28","kind":"grant","acquired":true,"shares":39000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 3 installments as follows: 13,000 shall vest on each of January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":108000,"source":{"system":"sec-edgar","filing":"0001209191-22-043765","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000120919122043765/doc4.xml","form_type":"4"}},{"id":2444627,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":27831,"kind":"person","name":"Silberman David","position":1,"cik":"0001867998","reported_name":"Silberman David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-06T01:32:00.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option will vest in 4 installments as follows: 8,000 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026."}],"balance_after":32000,"derivative":{"exercise_price":13.89,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001213900-22-000805","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000805/ownership.xml","form_type":"4"}},{"id":2444626,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":27831,"kind":"person","name":"Silberman David","position":1,"cik":"0001867998","reported_name":"Silberman David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-06T01:32:00.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":19000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that will vest in 4 installments as follows: 4,750 shall vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis."}],"balance_after":69000,"source":{"system":"sec-edgar","filing":"0001213900-22-000805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390022000805/ownership.xml","form_type":"4"}},{"id":2582055,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":27831,"kind":"person","name":"Silberman David","position":1,"cik":"0001867998","reported_name":"Silberman David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-02T20:48:34.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Options will vest in four equal installments of 12,500 on each of June 27, 2022, June 27, 2023, June 27, 2024 and June 27, 2025."}],"balance_after":50000,"derivative":{"exercise_price":20.19,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001213900-21-046413","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390021046413/ownership.xml","form_type":"4"}},{"id":2582054,"issuer":{"id":6311,"kind":"organization","name":"ORAMED PHARMACEUTICALS INC.","symbol":"ORMP"},"owners":[{"id":27831,"kind":"person","name":"Silberman David","position":1,"cik":"0001867998","reported_name":"Silberman David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-02T20:48:34.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents common stock underlying Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"date","element":"transactionDate","label":"F2","text":"The RSUs will vest as follows: 33,333 shall vest in three equal installments over a period of three years upon Issuer's common stock achieving a specified price per share, and 16,667 shall vest in three equal installments over a period of three years upon Issuer's achievement of certain business objectives."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001213900-21-046413","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1176309/000121390021046413/ownership.xml","form_type":"4"}}]}